Report ID: SQMIG35A4057
Report ID: SQMIG35A4057
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A4057 |
Region:
Global |
Published Date: July, 2026
Pages:
157
|Tables:
170
|Figures:
79
Global Endovascular Aneurysm Repair Market size was valued at USD 3.30 Billion in 2024 and is poised to grow from USD 3.46 Billion in 2025 to USD 5.03 Billion by 2033, growing at a CAGR of 4.8% during the forecast period (2026-2033).
Reimbursement policy is the key driver for the endovascular aneurysm repair market trends as hospital purchasing is driven by payer policies. U.S. and German insurers introduced bundled payments incentivizing shorter hospital stays and fewer complications. This led to a switch in clinicians from open repair to EVAR, resulting in a 12 % per year increase in device shipments from 2020 to 2024. This incentive has also resulted in the development of low-profile grafts by manufacturers for smaller vessels, like Gore’s 14-French platform used in community hospitals without large-bore access. Reimbursement, device innovation and geographic reach combine to create a cycle that expands the market and brings minimally invasive therapy to patients earlier in the course of their disease.
How is AI-driven Imaging Influencing the Endovascular Aneurysm Repair Market?
AI-based imaging is transforming endovascular aneurysm repair market share, enabling quicker and more precise anatomical assessments to assist in device selection and placement. Advanced algorithms automate vessel segmentation, aneurysm morphology detection and optimal landing zone prediction, minimizing dependence on manual interpretation. Case planning is faster, procedure times are shorter and radiation exposure is less, making minimally invasive repair more appealing to clinicians and patients. As the market grows, Hospitals are adopting these tools to improve outcomes and streamline workflows solidifying the shift toward technology enabled vascular care.
An AI enhanced imaging platform was launched in October 2023 to improve pre-procedural planning and reduce operative time, supporting market growth and efficiency.
Market snapshot - (2026-2033)
Global Market Size
USD 3.3 Billion
Largest Segment
Abdominal Aortic Aneurysm (AAA) Stent Grafts
Fastest Growth
Fenestrated Endovascular Grafts
Growth Rate
4.8% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global endovascular aneurysm repair market is segmented by product type, procedure type, aneurysm type, material type, end user, application and region. Based on product type, the market is segmented into abdominal aortic aneurysm (AAA) stent grafts, thoracic aortic aneurysm (TAA) stent grafts, fenestrated endovascular grafts and branched endovascular grafts. Based on procedure type, the market is segmented into elective endovascular aneurysm repair (EVAR) and emergency endovascular aneurysm repair (EVAR). Based on aneurysm type, the market is segmented into abdominal aortic aneurysm (AAA), thoracic aortic aneurysm (TAA) and thoracoabdominal aortic aneurysm (TAAA). Based on material type, the market is segmented into polyester-based grafts, eptfe-based grafts and hybrid materials. Based on end user, the market is segmented into hospitals, cardiac & vascular centers and ambulatory surgical centers. Based on application, the market is segmented into primary aneurysm repair and revision & secondary procedures. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
What Role Do Abdominal Aortic Aneurysm Stent Grafts Play in Shaping the Evar Market?
The dominant segment is abdominal aortic aneurysm (AAA) stent grafts, fueled by long-standing clinical evidence, widespread physician familiarity, and extensive product portfolios covering a broad range of vessel anatomies. Its track record of proven safety supports hospitals’ prioritization of procurement and reimbursement pathways remain well aligned, further supporting adoption in both elective and emergent settings. With this, manufacturers direct their R&D investments into this segment, keeping market leadership and ensuring continuous innovation pipelines through collaborative clinical initiatives.
However, fenestrated endovascular grafts are witnessing the strongest growth momentum as complex aortic anatomies necessitate customized solutions. Advances in imaging and manufacturing allow precise fenestration placement, making the procedure suitable for patients who were previously not considered suitable candidates for standard grafts. This innovation generates clinical interest, opens up new procedural avenues, and accelerates endovascular aneurysm repair market forecast expansion.
How are ePTFE‑Based Grafts Influencing Device Selection Decisions in the Evar Market?
ePTFE-based grafts segment is characterized by biocompatibility and flexibility that allows seamless integration with different vascular anatomies thus reducing procedural complications. The fatigue resistance of the material is appreciated by our surgeons, leading to longer device life and confidence in long term results. These characteristics align well with the criteria of hospital purchasing committees, which value reliability and safety, and will drive its adoption for a range of simple to complex repairs, establishing it as the dominant player in the evar market and shaping future device development.
On the other hand, hybrid materials are emerging as the key high growth area as they combine the strengths of polyester and eptfe, delivering enhanced durability while maintaining flexibility. Research continues to reveal coating technologies that improve seal performance and appeal to clinicians seeking flexible options for anatomies. This momentum is driving product pipelines and fueling endovascular aneurysm repair market growth.
To get detailed segments analysis, Request a Free Sample Report
North America's dominance is supported by a mature healthcare ecosystem that is favorable to minimally invasive innovation and rapid technology integration. The wide reimbursement schemes are promoting quick adoption, and the leading medical device makers have a solid position with continuous product enhancement. Universities and research institutions provide high quality clinical training and generate robust evidence for the effectiveness of procedures. Integrated health systems coordinate the delivery of care to ensure high procedural volumes and standard quality practices that engender confidence among clinicians and patients. Collaborative industry-physician relationships further accelerate the diffusion of emerging techniques, further cementing the region’s leadership position.
Endovascular aneurysm repair market regional outlook in United States thrives on deep clinical expertise and a supportive payer environment that rewards value‑based outcomes. Prominent device innovators anchor research hubs that accelerate product cycles, while large hospital networks provide the scale necessary for routine implementation. Strong regulatory pathways streamline approvals, allowing clinicians early access to cutting‑edge technology and fostering a culture of continuous improvement across vascular specialties.
Endovascular aneurysm repair market regional forecast in Canada benefits from a publicly funded system that emphasizes cost‑effectiveness and patient safety. National health agencies promote evidence‑based guidelines, encouraging uniform adoption across provinces. Collaborative networks among academic centers and community hospitals facilitate knowledge transfer, while local manufacturing partnerships enhance device availability and reduce supply chain complexities.
Harmonized regulatory standards that facilitate market entry and encourage cross‑border collaboration are fueling Europe’s rapid expansion. Across member states, comprehensive reimbursement policies reduce financial barriers for providers, while aging demographics increase clinical demand for less invasive solutions. Strong research ecosystems create high-quality clinical data that enables guideline integration and physician confidence. Moreover, a robust focus on health technology assessment ensures that innovative devices meet rigorous standards for effectiveness, driving long-term growth across the continent.
Endovascular aneurysm repair market penetration in Germany is characterized by a well‑established network of specialist centers that prioritize procedural excellence. Close collaboration between industry and leading university hospitals drives early adoption of next‑generation devices. Reimbursement structures aligned with outcome metrics incentivize the use of minimally invasive techniques, while regulatory alignment with broader European directives streamlines product availability.
Endovascular aneurysm repair market analysis in United Kingdom experiences swift growth as national health services champion cost‑effective, patient‑centred interventions. Clinical pathways integrate multidisciplinary teams that accelerate decision‑making, and emergent training programmes expand the pool of qualified specialists. Funding mechanisms that reward clinical efficiency further stimulate uptake, positioning the market as a leading example of rapid adoption within the region.
Endovascular aneurysm repair industry outlook in France is emerging through strategic investments in vascular research and a progressive regulatory environment. Public health initiatives emphasize early detection and minimally invasive treatment, encouraging hospitals to adopt advanced technologies. Partnerships between domestic manufacturers and international innovators enhance product diversity, while evolving reimbursement frameworks support broader clinical implementation.
Asia Pacific is reinforcing its position with rising healthcare expenditure and focused policy reforms favouring minimally invasive care. Increasing awareness about vascular health has led to a demand for procedures that reduce hospital stay and improve recovery outcomes. Local manufacturers are gaining the capacity to manufacture sophisticated devices, reducing reliance on imports and building regional expertise. Collaborative clinical trials and education programmes enhance practitioner proficiency, making the region an emerging centre for endovascular innovation.
Endovascular aneurysm repair industry analysis in Japan benefits from a culture of precision medicine and an extensive network of specialized vascular centers. Government initiatives support the integration of advanced technologies into routine practice, while senior clinicians champion evidence‑based adoption. Strong domestic manufacturing ensures device customization for local patient anatomy, reinforcing confidence among healthcare providers.
Endovascular aneurysm repair sector in South Korea advances through aggressive investment in medical technology and a regulatory framework that accelerates device clearance. Academic hospitals serve as epicenters for training and research, fostering rapid skill acquisition among surgeons. Strategic collaborations with global manufacturers expand access to innovative solutions, positioning the market as a dynamic player within the wider Asia Pacific landscape.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Increasing Adoption of Minimally Invasive Techniques
Advancements in Imaging and Navigation
High Procedure Cost and Reimbursement
Limited Skilled Workforce Availability
Request Free Customization of this report to help us to meet your business objectives.
The endovascular aneurysm repair (EVAR) market is characterized by intense competition among leading medical device manufacturers focused on developing advanced minimally invasive solutions for the treatment of abdominal and thoracic aortic aneurysms. Market participants compete through continuous product innovation, clinical research, strategic partnerships, regulatory approvals, and geographic expansion. Companies are increasingly investing in next-generation stent-graft technologies, imaging-guided procedures, and customized endovascular solutions to improve procedural outcomes and patient safety. Furthermore, growing adoption of minimally invasive vascular interventions and advancements in device design continue to drive innovation and market growth.
Top Player’s Company Profile
Recent Developments in the Endovascular Aneurysm Repair Market
Minimally Invasive Expansion: Globally, hospitals are increasingly focusing on minimally invasive procedures to reduce recovery time for patients as well as the risk of complications. The change of strategy leads to the development of endovascular aneurysm repair as clinicians realize that it can give similar results to open repair, but with less trauma. As a result, healthcare providers are extending their interventional suites, investing in imaging technologies and incorporating EVAR into standard treatment pathways for a wider patient cohort, cementing the modality as a staple of vascular care in global clinical settings today.
Device Innovation Acceleration: Device designs are rapidly evolving to address anatomic variability and improve procedural ease. Innovations like low-profile delivery systems, repositionable stent-grafts, and integrated sealing technologies allow the treatment of previously ineligible patients and streamline the operator workflow. This relentless R&D focus accelerates learning curves, broadens candidacy and feeds competitive differentiation, spurring hospitals to upgrade equipment portfolios. This creates market demand for next generation platforms that offer better safety, less fluoroscopy time and increased procedural confidence for clinicians today.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. As per SkyQuest analysis, the global endovascular aneurysm repair market is mainly driven by the increasing adoption of minimally invasive techniques that reduce patient trauma and hospital stay time. The fast development of imaging and navigation technologies is the second catalyst in the market as it improves the accuracy of the procedures and reduces the learning curves. High device costs and limited reimbursement coverage represent a major constraint in the market, which slows adoption in cost-sensitive settings. North America is still the largest region, due to the maturity of the payers and strong manufacturer presence. The abdominal aortic aneurysm stent-graft segment leads in volume, due to the extensive clinical evidence and broad physician familiarity.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 3.3 Billion |
| Market size value in 2033 | USD 5.03 Billion |
| Growth Rate | 4.8% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Endovascular Aneurysm Repair Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Endovascular Aneurysm Repair Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Endovascular Aneurysm Repair Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Endovascular Aneurysm Repair Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
Global Endovascular Aneurysm Repair Market size was valued at USD 3.3 Billion in 2024 and is poised to grow from USD 3.46 Billion in 2025 to USD 5.03 Billion by 2033, growing at a CAGR of 4.8% during the forecast period (2026-2033).
The competitive landscape is shaped by aggressive capital inflows and strategic collaborations, with firms leveraging advanced sealing technologies and tissue‑stabilization platforms to differentiate their endovascular aneurysm repair solutions. Recent examples include Nectero Therapeutics securing a $96 million Series D round to accelerate its EAST system rollout and forging clinical partnerships for Phase II/III trials, while larger device makers are pursuing targeted acquisitions of niche innovators to broaden their product portfolios and accelerate market penetration. 'Medtronic plc', 'W. L. Gore & Associates, Inc.', 'Cook Medical LLC', 'Terumo Corporation', 'Endologix LLC', 'MicroPort Scientific Corporation', 'Artivion, Inc.', 'Cordis Corporation', 'Meril Life Sciences Pvt. Ltd.', 'Lepu Medical Technology (Beijing) Co., Ltd.', 'Endospan Ltd.', 'Braile Biomedica', 'Lifetech Scientific Corporation', 'Lombard Medical Technologies PLC', 'Boston Scientific Corporation', 'Eucatech AG', 'InSitu Technologies Inc.', 'Translumina GmbH', 'Bentley InnoMed GmbH', 'Vesalio LLC'
Minimally Invasive Expansion: Hospitals worldwide are increasingly prioritizing minimally invasive procedures to reduce patient recovery time and lower complication rates. This strategic shift drives adoption of endovascular aneurysm repair, as clinicians recognize its ability to deliver comparable outcomes to open surgery with less trauma. Consequently, healthcare providers are expanding their interventional suites, investing in imaging technologies, and integrating EVAR into standard treatment pathways for a broader patient cohort, positioning the modality as a core offering in vascular care across global clinical settings today.
Why does North America Dominate the Global Endovascular Aneurysm Repair Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients